IGI Laboratories, Inc. (IG) Monday said Jason Grenfell-Gardner has been appointed President and Chief Executive Officer of the firm, effective July 30.
Jason Grenfell-Gardner brings significant experience in the pharmaceutical industry, with a special focus on generics. He was most recently the Senior Vice President of Sales and Marketing for West-Ward Pharmaceuticals, the US Subsidiary of Hikma Pharmaceuticals.
Jason had a key role in the senior management team there, which grew the business from just over $100 million in 2008 to over $300 million in 2011. He strengthened West-Ward's presence in the sterile injectable space through the acquisition of Baxter International, Inc.'s multisource injectable business in 2011.
Jason originally joined Hikma Pharmaceuticals to lead its initial public offering in 2004, and later headed its business development efforts.
For comments and feedback: editorial@rttnews.com